Navigation Links
Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
Date:11/7/2010

medical countermeasure in the event of a smallpox release.  Chimerix has received significant funding from the National Institutes of Allergy and Infectious Disease to develop CMX001 for smallpox.  

Chimerix's second clinical-stage antiviral compound, CMX157, has completed Phase 1 clinical studies.  CMX157 is in development as a potent nucleoside analogue against multi-drug resistant HIV infections.  

Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, malaria and other global public health needs.  For additional information on Chimerix, please visit http://www.chimerix.com.

(1)  Source:  April 26, 2010 - MEMORANDUM FOR THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIES (www.whitehouse.gov)


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Chimerix to Present at 9th Annual BIO Investor Forum
2. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
3. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix to Present at Two Upcoming Investor Conferences
6. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
7. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
8. CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance
9. Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
10. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
11. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/bfqljk/global_and ... "Global and Chinese Hemodialysis Concentrates Industry Report 2014" ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , Global and Chinese ... and in-depth study on the current state of ... the Chinese situation. The report provides ...
(Date:10/25/2014)... , Oct. 24, 2014 In conjunction ... quarter 2014 financial results press release, you are invited ... broadcast live over the internet on Monday, November 3, ... Time). A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations."  If you ...
(Date:10/25/2014)... , Oct. 24, 2014  As the ... provide a company access to diverse skill sets ... and round-the clock business hours for efficiency. However, ... hurdles. According to recent research, ... such as seeing a project not move forward ...
Breaking Medicine Technology:Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. ... cold sores -- herpes simplex -- might increase the risk ... In fact, being a carrier of certain antibodies to the ... found. "The identification of a treatable cause [herpes ... said lead researcher Dr. Hugo Lovheim, an associate professor in ...
(Date:10/25/2014)... (HealthDay News) -- A large influx of international aid ... avoid tens of thousands of deaths from the widening ... Using a specially designed mathematical model, the ... in just one densely populated county of hard-hit Liberia ... Monrovia. The researchers said that if international aid ...
(Date:10/25/2014)... FRIDAY, Oct. 24, 2014 (HealthDay News) -- October,s shorter, ... as seasonal affective disorder, according to an expert. ... SAD, may feel overly tired, lack motivation and even ... SAD can lead to suicide, said Dr. Angelos Halaris, ... neurosciences at Loyola University Chicago Stitch School of Medicine. ...
(Date:10/22/2014)... On October 22, CBS will air an ... both fictional and real. The Charles E Holman ... to advocacy and philanthropy in the battle against Morgellons ... to impart truth and clarity about this misunderstood and ... misconceptions about Morgellons Disease (MD) and most ...
(Date:10/22/2014)... 2014 For Dr. Iris Hunter, a job ... an extension of her life’s mission. Her extensive experience in ... owner of FirstLight HomeCare, make it clear that Hunter’s mission ... that my work makes a difference in the lives of ... so after much research, I felt ready to start on ...
Breaking Medicine News(10 mins):Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2
... women doctors have been suspended for their alleged role ... operation beamed yesterday. // ,The doctors - ... Priyanaka Saxena (Sawaimadhopur), Madhu Mathur (Jhalawar), Rajkumar Choudhary and ... "awaiting posting order" and asked to report to the ...
... unhealthy levels of benzene in two diet drinks, which ... the market. , ,The two drinks that have ... and Rose's Diabetic Squash Concentrate. Stricter guidelines have been ... avoid benzene formation in the drinks., ,Benzene, ...
... adults scored the best in hearing abilities in the ... Non-Hispanic women were found to be sharper in hearing ... Themann, and Mark Stephenson at the National Institute for ... the hearing test results of more than 5,000 U.S. ...
... the Journal Thorax suggests that middle aged smokers with heavily ... obstructive// pulmonary disease (COPD) than others. ,COPD is ... diseases, such as emphysema and bronchitis, which block the airways ... excess of 1 million people are thought to have COPD ...
... of pancreatic surgery during the last 35 years at ... Charles J. Yeo, M.D., Samuel D. Gross Professor and ... Jefferson University and Thomas Jefferson University Hospital in Philadelphia ... revealed that contrary to what many both in and ...
... Great Ormond Street Hospital doctors have developed a novel method ... of five//. The test is very accurate and can be ... to the statistics it was found that respiratory disease affects ... 34% of weekly GP consultations and 15% of hospital admissions ...
Cached Medicine News:Health News:U.S: Prize for the best hearing category (ethnic groups) goes to…. Non-Hispanic Blacks 2Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 2Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 3
... CCR Medical's Articulating Tip Laryngoscopes ... in the Industry. The articulating ... by providing an improved view ... and Fiber Optic styles. We ...
German Style MacIntosh Fiber Optic Blade Laryngoscopes...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: